Biggest ALS gene study aims to unlock disease secrets

NCT ID NCT02327845

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at people with ALS and similar diseases like frontotemporal dementia and hereditary spastic paraplegia. Researchers want to understand how genes affect the disease and find biological markers (biomarkers) to help develop future treatments. About 708 participants, including family members, will provide data over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • California Pacific Medical Center (CPMC)

    San Francisco, California, 94115, United States

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

  • Eberhard Karls University of Tübingen

    Tübingen, Germany

  • Kansas University Medical Center (KUMC)

    Kansas City, Kansas, 66160, United States

  • Stanford University

    Palo Alto, California, 94304, United States

  • Twin Cities ALS Research Consortium

    Minneapolis, Minnesota, 55415, United States

  • University of California San Diego (UCSD)

    San Diego, California, 92093, United States

  • University of Cape Town

    Cape Town, South Africa

  • University of Iowa

    Iowa City, Iowa, 52242, United States

  • University of Miami

    Miami, Florida, 33136, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • University of Texas Health Science Center San Antonio (UTHSCSA)

    San Antonio, Texas, 78229, United States

  • University of Texas Southwestern (UTSW)

    Dallas, Texas, 75390, United States

  • University of Virginia (UVA)

    Charlottesville, Virginia, 22908, United States

  • Wake Forest University

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.